Moneycontrol PRO
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewscompanies

US watchdog sniffs Lupin's Tarapur facility, growls

The company said it will address the concerns raised by the watchdog and the news will not impact its revenue.

September 29, 2022 / 11:17 AM IST
Representative Image

Representative Image

Drug manufacturer Lupin informed bourses that it has received a warning letter from the US Food and Drug Administration (FDA) after an inspection of their facility in Maharashtra's Tarapur.

The company said it will address the concerns raised by USFDA and the news will not impact its revenue.

The stock opened at Rs 674 on the BSE and is currently trading at Rs 661.50. It closed at Rs 670 yesterday.

 
Moneycontrol News
first published: Sep 29, 2022 11:17 am